Tag: heart disease

The pharmaceutical landscape for diabetic complications has reached a significant milestone following the U.S. Food and Drug Administration’s (FDA) decision to expand the indication for Bayer’s KERENDIA (finerenone). This approval marks the first time in over three decades that a new pharmacological intervention has been authorized to specifically address the progression of chronic kidney disease…

The Endocrine Society has officially signaled its support for the newly introduced Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, a significant piece of bipartisan legislation aimed at curbing the soaring costs of insulin for millions of Americans. Introduced in the House of Representatives by a cross-party coalition including Representatives Diana DeGette…

The transition from pediatric to adult medical care represents one of the most precarious phases in the longitudinal management of patients with chronic endocrine disorders, particularly those surviving pediatric pituitary tumors (PPTs). During the ENDO 2026 conference held in June, Kevin C. J. Yuen, MD, FRCP, FEAA, a leading neuroendocrinologist and medical director of the…

A comprehensive review of clinical and laboratory evidence has identified a critical "Goldilocks zone" for testosterone levels in men, suggesting that both abnormally low and excessively high levels of the hormone significantly increase the risk of developing atrial fibrillation (AFib). The study, published in the Journal of the Endocrine Society, calls for a paradigm shift…

The medical community is witnessing a potential paradigm shift in the management of secondary hypertension following the unveiling of a sophisticated artificial intelligence model designed to identify primary aldosteronism through routine clinical data. Presented at the ENDO 2026 annual meeting in Chicago, Illinois, the research leverages three decades of electronic health records (EHR) to address…

The Endocrine Society has issued a comprehensive Scientific Statement that fundamentally redefines the medical community’s approach to obesity, moving the focus from simple weight reduction to a holistic management of metabolic health. This new directive arrives at a critical juncture in public health, as the rapid emergence and adoption of highly effective medications, such as…

The detection of endocrine-disrupting chemicals (EDCs) in breast milk and the urine of infants from birth through the first six months of life has raised significant concerns regarding environmental exposure during the most vulnerable stages of human development. According to a landmark study presented at ENDO 2026, the Endocrine Society’s annual meeting held in Chicago,…

The Endocrine Society has officially named 13 distinguished medical professionals and scientists as the recipients of its 2027 Laureate Awards. Regarded as the highest honors in the field of endocrinology, these awards recognize a diverse cohort of experts who have made transformative contributions to the study and treatment of hormone-related conditions. Since its establishment in…

The landscape of pediatric endocrinology is witnessing a pivotal shift as researchers integrate advanced computational power with complex biochemical analysis. A recent commentary published in The Journal of Clinical Endocrinology & Metabolism (JCEM) has spotlighted a transformative study that utilizes machine learning (ML) to address the diagnostic complexities of congenital disorders of adrenal steroidogenesis (CDAS).…

The landscape of modern endocrinology is shifting rapidly as new clinical data reveals the profound interconnectedness of lifestyle habits, environmental exposure, and technological interventions in managing metabolic health. Recent findings published in leading medical journals and reports from public health organizations underscore a critical period for endocrine science, where minor adjustments in daily routines—such as…